1. Home
  2. CRGX vs TGB Comparison

CRGX vs TGB Comparison

Compare CRGX & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • TGB
  • Stock Information
  • Founded
  • CRGX 2021
  • TGB 1966
  • Country
  • CRGX United States
  • TGB Canada
  • Employees
  • CRGX N/A
  • TGB N/A
  • Industry
  • CRGX
  • TGB Precious Metals
  • Sector
  • CRGX
  • TGB Basic Materials
  • Exchange
  • CRGX Nasdaq
  • TGB Nasdaq
  • Market Cap
  • CRGX 621.4M
  • TGB 584.6M
  • IPO Year
  • CRGX 2023
  • TGB N/A
  • Fundamental
  • Price
  • CRGX $12.04
  • TGB $2.05
  • Analyst Decision
  • CRGX Strong Buy
  • TGB Strong Buy
  • Analyst Count
  • CRGX 6
  • TGB 1
  • Target Price
  • CRGX $31.80
  • TGB $3.50
  • AVG Volume (30 Days)
  • CRGX 293.5K
  • TGB 2.8M
  • Earning Date
  • CRGX 11-12-2024
  • TGB 03-06-2025
  • Dividend Yield
  • CRGX N/A
  • TGB N/A
  • EPS Growth
  • CRGX N/A
  • TGB 207.78
  • EPS
  • CRGX N/A
  • TGB 0.12
  • Revenue
  • CRGX N/A
  • TGB $425,387,060.00
  • Revenue This Year
  • CRGX N/A
  • TGB $18.85
  • Revenue Next Year
  • CRGX N/A
  • TGB $19.29
  • P/E Ratio
  • CRGX N/A
  • TGB $17.39
  • Revenue Growth
  • CRGX N/A
  • TGB 39.36
  • 52 Week Low
  • CRGX $11.80
  • TGB $1.27
  • 52 Week High
  • CRGX $33.92
  • TGB $3.15
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 34.44
  • TGB 50.77
  • Support Level
  • CRGX $13.65
  • TGB $2.01
  • Resistance Level
  • CRGX $15.75
  • TGB $2.28
  • Average True Range (ATR)
  • CRGX 1.22
  • TGB 0.09
  • MACD
  • CRGX -0.03
  • TGB 0.02
  • Stochastic Oscillator
  • CRGX 5.83
  • TGB 41.03

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About TGB Taseko Mines Ltd.

Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.

Share on Social Networks: